Co-Diagnostics, Inc.
CODX
$0.344
$0.037412.20%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -5.96% | -11.62% | -22.34% | -71.09% | -91.70% |
| Total Other Revenue | -94.91% | -51.46% | -45.97% | 186.35% | -- |
| Total Revenue | -89.02% | -47.63% | -42.53% | 57.16% | 25.24% |
| Cost of Revenue | -83.48% | -79.93% | -76.13% | 114.20% | 63.48% |
| Gross Profit | -92.73% | -1.78% | 11.00% | 23.37% | 8.24% |
| SG&A Expenses | -5.12% | -6.29% | -2.36% | -8.60% | -11.82% |
| Depreciation & Amortization | 0.16% | 6.59% | 11.93% | 9.61% | 3.72% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.89% | -15.74% | -11.15% | 2.27% | 2.86% |
| Operating Income | -0.13% | 10.79% | 6.15% | 3.88% | 1.31% |
| Income Before Tax | -0.41% | 9.07% | 1.39% | 28.54% | 24.92% |
| Income Tax Expenses | -97.83% | 109.41% | 102.07% | 139.99% | 118.09% |
| Earnings from Continuing Operations | 4.20% | 7.79% | -6.53% | 3.00% | 0.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.20% | 7.79% | -6.53% | 3.00% | 0.98% |
| EBIT | -0.13% | 10.79% | 6.15% | 3.88% | 1.31% |
| EBITDA | -0.13% | 11.31% | 6.68% | 4.29% | 1.47% |
| EPS Basic | 9.65% | 11.94% | -2.99% | 4.52% | 1.52% |
| Normalized Basic EPS | 3.31% | 14.24% | 8.68% | 6.32% | 2.11% |
| EPS Diluted | 9.05% | 11.59% | -2.52% | 4.87% | 2.08% |
| Normalized Diluted EPS | 3.31% | 14.24% | 8.68% | 6.32% | 2.11% |
| Average Basic Shares Outstanding | 6.51% | 4.91% | 3.35% | 2.05% | -0.57% |
| Average Diluted Shares Outstanding | 6.51% | 4.91% | 3.35% | 2.05% | -0.57% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |